BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8406980)

  • 1. The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma.
    Eskelinen M; Lipponen P; Aitto-Oja L; Hall O; Syrjänen K
    Int J Cancer; 1993 Oct; 55(4):547-54. PubMed ID: 8406980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of classic and quantitative prognostic factors in colorectal cancer.
    Ropponen K; Eskelinen M; Kosma VM; Lipponen P; Paakkinen P; Alhava E
    Anticancer Res; 1996; 16(6B):3875-82. PubMed ID: 9042274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer in young women: clinical, histological and morphometric prognostic factors.
    Eskelinen M; Lipponen P; Aaltomaa S; Kosma VM; Syrjänen K; Alhava E
    Anticancer Res; 1992; 12(4):1237-42. PubMed ID: 1503415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classic prognostic factors, flow cytometric data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer.
    Lipponen PK; Eskelinen MJ; Kiviranta J; Nordling S
    Anticancer Res; 1991; 11(2):911-6. PubMed ID: 2064350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of T1-2 GI-II transitional cell bladder cancer; evaluation by histoquantitative methods.
    Lipponen PK; Eskelinen MJ; Sotarauta M
    Scand J Urol Nephrol; 1991; 25(2):129-34. PubMed ID: 1871558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent clinical, histological and quantitative prognostic factors in transitional-cell bladder tumours, with special reference to mitotic frequency.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H
    Int J Cancer; 1992 May; 51(3):396-403. PubMed ID: 1592531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of superficial bladder cancer by nuclear image analysis.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H
    Eur J Cancer; 1992; 29A(1):61-5. PubMed ID: 1445747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of ovarian carcinomas: prediction by histoquantitative methods.
    Haapasalo H; Collan Y; Atkin NB; Pesonen E; Seppä A
    Histopathology; 1989 Aug; 15(2):167-78. PubMed ID: 2777218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer.
    Eskelinen M; Lipponen P; Papinaho S; Aaltomaa S; Kosma VM; Klemi P; Syrjänen K
    Int J Cancer; 1992 Jun; 51(4):555-61. PubMed ID: 1601520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear morphometry in grading transitional cell bladder cancer compared with subjective histological grading.
    Lipponen P; Eskelinen M
    Anticancer Res; 1990; 10(6):1725-30. PubMed ID: 2285249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction.
    Lipponen PK; Eskelinen MJ; Kiviranta J; Pesonen E
    J Urol; 1991 Dec; 146(6):1535-40. PubMed ID: 1942335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic scores combining clinical, histological and morphometric variables in assessment of the disease outcome in female breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Int J Cancer; 1991 Dec; 49(6):886-92. PubMed ID: 1959993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R
    Eur J Cancer; 1992; 29A(1):69-75. PubMed ID: 1445749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitotic indexes as prognostic predictors in female breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    J Cancer Res Clin Oncol; 1992; 118(1):75-81. PubMed ID: 1729263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of nuclear morphometric variables as prognostic predictors in breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Anticancer Res; 1991; 11(4):1663-9. PubMed ID: 1746922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferation indices as independent prognostic factors in papillary Ta-T1 transitional cell bladder tumours.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Terho R; Nordling S
    Br J Urol; 1993 Oct; 72(4):451-7. PubMed ID: 8261303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma.
    Lipponen P; Eskelinen M; Syrjänen K
    Br J Cancer; 1995 Apr; 71(4):863-7. PubMed ID: 7710955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
    Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
    Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma.
    Sika-Paotonu D; Bethwaite PB; McCredie MR; William Jordan T; Delahunt B
    Am J Surg Pathol; 2006 Sep; 30(9):1091-6. PubMed ID: 16931953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.